KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Clinical trial NCT00549198 · COMPLETED

Trial details

NCT number: NCT00549198
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus I HIV Infection

Start date: 2007-06-01
Primary completion: 2009-12-01
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.